## **Core Concept**
Angiogenic factors are substances that promote the formation of new blood vessels, a process known as angiogenesis. This process is crucial in growth, development, wound healing, and also in pathological conditions such as cancer. Various factors can stimulate or inhibit angiogenesis.

## **Why the Correct Answer is Right**
The correct answer, , is known to inhibit angiogenesis. It is a protein that can bind to vascular endothelial growth factor (VEGF) and prevent it from interacting with its receptors on the surface of endothelial cells, thereby inhibiting angiogenesis. VEGF is a key promoter of angiogenesis.

## **Why Each Wrong Option is Incorrect**
- **Option A:** is known to be involved in promoting angiogenesis. It is a receptor tyrosine kinase that, when activated by its ligands (such as VEGF), can stimulate the proliferation and migration of endothelial cells, which are critical steps in angiogenesis.
- **Option B:** is also a promoter of angiogenesis. It acts by stimulating the endothelial cells to proliferate and form new blood vessels.
- **Option D:** promotes angiogenesis through its action on endothelial cells, enhancing their survival, proliferation, and migration.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the balance between pro-angiogenic and anti-angiogenic factors determines the net effect on angiogenesis. In cancer therapy, targeting angiogenesis (e.g., with bevacizumab, which targets VEGF) has become a strategy to inhibit tumor growth by cutting off its blood supply.

## **Correct Answer:** . Endostatin.